In addition to the germline and somatic coding mutations in key MMR enzymes, transcriptional silencing of MLH1 through promoter hypermethylation (MLH1 methylation) was observed in 10–20% of all CRC cases. The gene discussed is MLH1; the disease is colorectal carcinoma.